- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targets in triple negative breast cancer
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PATHOLOGY
Volume 66, Issue 6, Pages 530-542
Publisher
BMJ
Online
2013-02-23
DOI
10.1136/jclinpath-2012-201361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40.
- (2017) H. D. Bear et al. JOURNAL OF CLINICAL ONCOLOGY
- Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells
- (2015) Oncotarget
- An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer
- (2012) Hui Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer
- (2012) Tobias J. Grob et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells
- (2012) Mayu Yunokawa et al. CANCER SCIENCE
- Biomarker and Pharmacologic Evaluation of the -Secretase Inhibitor PF-03084014 in Breast Cancer Models
- (2012) C. C. Zhang et al. CLINICAL CANCER RESEARCH
- Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer
- (2012) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
- (2012) S. P. Glaser et al. GENES & DEVELOPMENT
- Prognostic influence of BCL2 expression in breast cancer
- (2012) Ki-Tae Hwang et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of Triple-Negative Breast Cancer Phenotype on Prognosis in Patients with Stage I Breast Cancer
- (2012) Jeong Eun Kim et al. Journal of Breast Cancer
- Pretreatment with AT-101 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of breast cancer cells by inducing death receptors 4 and 5 protein levels
- (2012) Asli Kisim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
- (2012) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer
- (2012) Lisa A. Carey et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
- (2012) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characteristic Genes in Luminal Subtype Breast Tumors with CD44+CD24–/Low Gene Expression Signature
- (2012) Y. Tsunoda et al. ONCOLOGY
- Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo
- (2012) Y. Lombardo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets
- (2011) S. M. Schoenwaelder et al. BLOOD
- Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial
- (2011) Mogens Bernsdorf et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of anti-DR5 and chemotherapy on basal-like breast cancer
- (2011) Patsy G. Oliver et al. BREAST CANCER RESEARCH AND TREATMENT
- Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity
- (2011) Angelina I. Londoño-Joshi et al. BREAST CANCER RESEARCH AND TREATMENT
- Developmental pathways in breast cancer and breast tumor-initiating cells: Therapeutic implications
- (2011) Julia Izrailit et al. CANCER LETTERS
- Abstract P1-11-07: Results of a Phase II Study of Neoadjuvant Platinum/Taxane Based Chemotherapy and Erlotinib for Triple Negative Breast Cancer
- (2011) P Sharma et al. CANCER RESEARCH
- Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer
- (2011) S. A. O'Toole et al. CANCER RESEARCH
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
- (2011) P N Kelly et al. CELL DEATH AND DIFFERENTIATION
- Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
- (2011) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
- (2011) Andreas Strasser et al. EMBO JOURNAL
- Haematologic toxicities associated with the addition of bevacizumab in cancer patients
- (2011) Fabio A.B. Schutz et al. EUROPEAN JOURNAL OF CANCER
- Metalloprotease-Disintegrin ADAM12 Expression Is Regulated by Notch Signaling via MicroRNA-29
- (2011) Hui Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Congestive Heart Failure Risk in Patients With Breast Cancer Treated With Bevacizumab
- (2011) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer
- (2011) P. M. McGowan et al. MOLECULAR CANCER RESEARCH
- A Monoclonal Antibody against Human Notch1 Ligand-Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem-like Cells
- (2011) A. Sharma et al. MOLECULAR CANCER THERAPEUTICS
- Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
- (2011) Dan R Robinson et al. NATURE MEDICINE
- Treatment of HER2-positive breast cancer: current status and future perspectives
- (2011) Carlos L. Arteaga et al. Nature Reviews Clinical Oncology
- Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
- (2011) Joyce O'Shaughnessy et al. NEW ENGLAND JOURNAL OF MEDICINE
- FZD7 has a critical role in cell proliferation in triple negative breast cancer
- (2011) L Yang et al. ONCOGENE
- Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61
- (2011) L G Harris et al. ONCOGENE
- Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer
- (2011) J. Baselga ONCOLOGIST
- Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
- (2011) S. R. Oakes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
- (2010) Andrey I. Khramtsov et al. AMERICAN JOURNAL OF PATHOLOGY
- Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers
- (2010) Aye Aye Thike et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes
- (2010) F. A. B. Schutz et al. ANNALS OF ONCOLOGY
- DNA repair signature is associated with anthracycline response in triple negative breast cancer patients
- (2010) A. A. Rodriguez et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo
- (2010) Clint Mitchell et al. CANCER BIOLOGY & THERAPY
- Triple-Negative Breast Cancer
- (2010) Ayca Gucalp et al. CANCER JOURNAL
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells
- (2010) O Kutuk et al. CELL DEATH AND DIFFERENTIATION
- Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in Culture
- (2010) Yi Arial Zeng et al. Cell Stem Cell
- Targeting IAPs as An Approach to Anti-Cancer Therapy
- (2010) Christopher S. Straub CURRENT TOPICS IN MEDICINAL CHEMISTRY
- TRAIL receptor signaling and therapeutics
- (2010) Junaid Abdulghani et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype
- (2010) Sarah J Zardawi et al. HISTOPATHOLOGY
- The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-dependent and Beclin 1-independent Cytoprotective Autophagy in Cancer Cells
- (2010) Ping Gao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic Behavior of Breast Cancer Subtypes
- (2010) Hagen Kennecke et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer molecular profiling with single sample predictors: a retrospective analysis
- (2010) Britta Weigelt et al. LANCET ONCOLOGY
- β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation
- (2010) Felipe C Geyer et al. MODERN PATHOLOGY
- β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast
- (2010) Magali Lacroix-Triki et al. MODERN PATHOLOGY
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
- (2010) Sunil Badve et al. MODERN PATHOLOGY
- Notch Signaling Pathway as a Therapeutic Target in Breast Cancer
- (2010) H. Al-Hussaini et al. MOLECULAR CANCER THERAPEUTICS
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors
- (2010) H Ling et al. ONCOGENE
- Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
- (2010) C. G. Fedele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer
- (2009) G. Frasci et al. ANNALS OF ONCOLOGY
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer
- (2009) Karin Rennstam et al. BREAST CANCER RESEARCH AND TREATMENT
- Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells
- (2009) Elif Damla Arisan et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells
- (2009) S Rasul et al. BRITISH JOURNAL OF CANCER
- Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
- (2009) B. T. Hennessy et al. CANCER RESEARCH
- Preclinical Profile of a Potent -Secretase Inhibitor Targeting Notch Signaling with In vivo Efficacy and Pharmacodynamic Properties
- (2009) L. Luistro et al. CANCER RESEARCH
- The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
- (2009) Raphael Kopan et al. CELL
- DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
- (2009) Timothy Hoey et al. Cell Stem Cell
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
- (2009) M. H. Kang et al. CLINICAL CANCER RESEARCH
- The Hedgehog signalling pathway as a therapeutic target in early breast cancer development
- (2009) Sandra A O'Toole et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
- (2009) Elena López-Knowles et al. INTERNATIONAL JOURNAL OF CANCER
- Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
- (2009) Judith Hugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia
- (2009) K D Mason et al. LEUKEMIA
- Direct inhibition of the NOTCH transcription factor complex
- (2009) Raymond E. Moellering et al. NATURE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mimicking the BH3 domain to kill cancer cells
- (2009) T Ni Chonghaile et al. ONCOGENE
- Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivity
- (2008) Giuseppe Viale et al. BREAST CANCER RESEARCH AND TREATMENT
- Opposite Effects of Notch-1 and Notch-2 on Mesothelioma Cell Survival under Hypoxia Are Exerted through the Akt Pathway
- (2008) I. Graziani et al. CANCER RESEARCH
- Phosphatase and Tensin Homologue Deleted on Chromosome 10 Deficiency Accelerates Tumor Induction in a Mouse Model of ErbB-2 Mammary Tumorigenesis
- (2008) N. Dourdin et al. CANCER RESEARCH
- Alteration of the Mitochondrial Apoptotic Pathway Is Key to Acquired Paclitaxel Resistance and Can Be Reversed by ABT-737
- (2008) O. Kutuk et al. CANCER RESEARCH
- Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the Breast
- (2008) M. J. Hayes et al. CLINICAL CANCER RESEARCH
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer
- (2008) S. L. Moulder et al. CLINICAL CANCER RESEARCH
- A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
- (2008) Erinna F. Lee et al. JOURNAL OF CELL BIOLOGY
- The molecular logic of Notch signaling - a structural and biochemical perspective
- (2008) W. R. Gordon et al. JOURNAL OF CELL SCIENCE
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- A paracrine requirement for hedgehog signalling in cancer
- (2008) Robert L. Yauch et al. NATURE
- More complicated than it looks: assembly of Notch pathway transcription complexes
- (2008) R A Kovall ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started